01394cam0-22004691i-450-99000041523040332120080310150910.0000041523FED01000041523(Aleph)000041523FED0100004152320020821d1981----km-y0itay50------baitaITy-------001yyIsolamenti termici impermeabilizzazioni sigillatureGennaro BraciglianoMilanoItec19812 v.29 cm1.: Guida alla progettazione edilizia2.: Cento prodotti a confrontoSigillantiMateriali EdiliziaIsolamento nelle CostruzioniEdiliziaIsolamento termico693.8691693.832Bracigliano,Gennaro331797ITUNINARICAUNIMARCBK99000041523040332108 C 706907 (AT)DINED08 C 716970/1 (AT)DINED13 E 06 1832790FINBC13 E 06 1732789FINBC08 AA 963936 C.E.DINED08 AA 953935 C.E.DINED1520053336DCATA1520063336DCATADINEDFINBCIsolamenti termici impermeabilizzazioni sigillature327121UNINA05000nam 2201345z- 450 991058021260332120220706(CKB)5690000000011962(oapen)https://directory.doabooks.org/handle/20.500.12854/87516(oapen)doab87516(EXLCZ)99569000000001196220202207d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierOncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and InnovationBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (346 p.)3-0365-4532-8 3-0365-4531-X The road of acceptance of oncologic thermotherapy/hyperthermia as a synergistic modality in combination with standard oncologic therapies is still bumpy. This is partially due to the lack of level I evidence from international, multicentric, randomized clinical trials including large patient numbers and a long term follow-up. Therefore we need more level I EVIDENCE from clinical trials, we need HARMONISATION and global acceptance for existing technologies and a common language understood by all stakeholders and we need INNOVATION in the fields of biology, clinics and technology to move thermotherapy/hyperthermia forward. This is the main focus of this reprint. In this reprintyou find carefully selected and peer-reviewed contributions from Africa, America, Asia, and Europe. The published papers from leading scientists from all over the world covering a broad range of timely research topics might also help to strengthen thermotherapy on a global level.Oncologic ThermoradiotherapyMedicine and NursingbicsscOncologybicsscabscopal effectadaptive planningantigen patternbioelectromagneticsbiological modelingbiomarkerbrachytherapybreast cancercancercellular selectioncervical cancerchemoradiotherapychemotherapyclinical evidencecomplexityconductivity reconstructioncost-effectivedanger signaldeep hyperthermiadendritic cell activationfractionationhead and neck cancerhead and neck cancershyperthermiahyperthermia treatment planninghyperthermia treatment sequencehypoxiaimmune checkpoint moleculesimmune phenotypeimmune responseimmune system in silicoimmune-effectsinducedintensity-modulated radiotherapyinterstitial hyperthermialinear quadratic modellocal tumor controllocally advanced cervical cancerloco-regional hyperthermialow-middle-income group countriesmeta-analysismoderate hyperthermiamodulated electro-hyperthermian/aneoadjuvant chemoradiationoncologyoxygen consumption ratepatterns of careperceptronperfusionperfusion estimationpreclinical dataprostateprostate cancerprostatic neoplasmsradiation therapyradiative hyperthermiaradiosensitiserradiotherapyrectal cancerrecurrent breast cancersregional hyperthermiareimbursementreirradiationreoxygenationresource-constrained settingsurvivalsystems medicinetemperature monitoringtemperature optimizationthermal dosethermal dosimetrythermometric parametersthermoradiotherapytreatment outcometreatment plan optimizationtumour controlMedicine and NursingOncologyBodis Stephanedt1326273Ghadjar PirusedtVan Rhoon Gerard CedtBodis StephanothGhadjar PirusothVan Rhoon Gerard CothBOOK9910580212603321Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation3037243UNINA